Veeva Systems Inc(VEEV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 10 at 4:00 PM ET (Korea 9/11 05:00)
Full metrics table
| Index | S&P 500 | P/E | 42.94 | EPS (ttm) | 6.08 | Insider Own | 8.83% | Shs Outstand | 161.8M | Perf Week | -7.03% |
| Market Cap | 42.25B | Forward P/E | 25.45 | EPS next Y | 11.02% | Insider Trans | -0.37% | Shs Float | 147.6M | Perf Month | 10.31% |
| Enterprise Value | 35.16B | PEG | 2.03 | EPS next Q | 2.34 | Inst Own | 92.51% | Short Float | 3.96% | Perf Quarter | 59.37% |
| Income | 1.01B | P/S | 12.22 | EPS this Y | 14.01% | Inst Trans | 3.11% | Short Ratio | 2.89 | Perf Half Y | 39.49% |
| Sales | 3.46B | P/B | 5.68 | EPS next 5Y | 12.51% | ROA | 11.9% | Short Interest | 5.84M | Perf YTD | 16.91% |
| Book/sh | 45.92 | P/C | 5.83 | EPS past 3/5Y | 21.93% 18.15% | ROE | 14.42% | 52W High | -15.95% ($310.50) | Perf Year | -4.96% |
| Cash/sh | 44.73 | P/FCF | 25.78 | Sales past 3/5Y | 14.03% 16.88% | ROIC | 13.41% | 52W Low | 76.28% ($148.05) | Perf 3Y | 18.46% |
| Dividend Est. | - | EV/EBITDA | 32.3 | EPS Y/Y TTM | 24.67% | Gross Margin | 74.83% | Volatility(W/M) | 2.78% 3.54% | Perf 5Y | -13.82% |
| Dividend TTM | - | EV/Sales | 10.17 | Sales Y/Y TTM | 16.5% | Oper. Margin | 29.93% | ATR (14) | 10.3 | Perf 10Y | 546.95% |
| Dividend Ex-Date | - | Quick Ratio | 5.46 | EPS Q/Q | 38.67% | Profit Margin | 29.34% | RSI (14) | 56.13 | Recom | 1.78 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.46 | Sales Q/Q | 17.6% | SMA20 | 0.04% ($260.88) | Beta | 0.95 | Target Price | $297.42 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2026/8/26 | SMA50 | 15.87% ($225.24) | Rel Volume | 0.42 | Prev Close | $260.8 |
| Employees | 7928 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 5.49% 2.49% | SMA200 | 31.5% ($198.46) | Avg Volume(3M) | 2.02M | Price | $260.98 |
| IPO | 2013/10/16 | Option/Short | Yes/Yes | Trades | 18966 | Volume | 851,410 | Change | 0.07% |
Company
VEEV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A leading provider of industry-specific cloud software for the global pharmaceutical and biotech industries, operating as a life sciences industry cloud pioneer. Founded in 2007 by Peter Gassner and headquartered in Pleasanton, California, USA, the company runs an integrated cloud platform spanning clinical, regulatory, and commercialization functions.
Over the past 1 year, roughly in the middle
16% below its 1-year high.
VEEV makes money exceptionally well
29.93% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.0% this year.
Tap to view numbers
The price looks about right
Trading at 42.9 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +18.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 92.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
EKG 0.07%
LGHT 0.06%
HEAL 0.04%
NLSI 0.04%
IHF 0.04%It is the largest in the industry
Based on market cap of $42B.
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
HQY $8B PER 34.1
FAQ
What kind of company is VEEV?
VEEV belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of VEEV?
The market cap of VEEV is approximately $42.3B, ranking 369 within its sector.
What is the P/E ratio of VEEV?
VEEV has a P/E ratio of approximately 42.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for VEEV?
VEEV has recorded a 52-week high of $310.50 and a low of $148.05.
